Rights and permissions
About this article
Cite this article
No cost savings with epoetin for premature neonates. Pharmacoecon. Outcomes News 10, 11 (1994). https://doi.org/10.1007/BF03289816
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03289816